์ฃผ์š” ์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ

๊ท€ํ•˜์˜ ๋ธŒ๋ผ์šฐ์ €๊ฐ€ ์™„๋ฒฝํ•˜๊ฒŒ ์ง€์›๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ์˜ต์…˜์ด ์žˆ๋Š” ๊ฒฝ์šฐ ์ตœ์‹  ๋ฒ„์ „์œผ๋กœ ์—…๊ทธ๋ ˆ์ด๋“œํ•˜๊ฑฐ๋‚˜ Mozilla Firefox, Microsoft Edge, Google Chrome ๋˜๋Š” Safari 14 ์ด์ƒ์„ ์‚ฌ์šฉํ•˜์„ธ์š”. ๊ฐ€๋Šฅํ•˜์ง€ ์•Š๊ฑฐ๋‚˜ ์ง€์›์ด ํ•„์š”ํ•œ ๊ฒฝ์šฐ ํ”ผ๋“œ๋ฐฑ์„ ๋ณด๋‚ด์ฃผ์„ธ์š”.

์ด ์ƒˆ๋กœ์šด ๊ฒฝํ—˜์— ๋Œ€ํ•œ ๊ท€ํ•˜์˜ ์˜๊ฒฌ์— ๊ฐ์‚ฌ๋“œ๋ฆฝ๋‹ˆ๋‹ค.์˜๊ฒฌ์„ ๋ง์”€ํ•ด ์ฃผ์„ธ์š”

Elsevier
์—˜์Šค๋น„์–ด์™€ ํ•จ๊ป˜ ์ถœํŒ

Profile

Marcus Conrad

MC

Marcus Conrad

Technical University of Munich, Germany

Prof. Dr. Marcus Conrad is a distinguished researcher at the Helmholtz Zentrum Mรผnchen, where he leads the Institute of Metabolism and Cell Death. His pioneering work focuses on the mechanisms of regulated cell death, particularly ferroptosis, and its implications in cancer and neurodegenerative diseases. With a strong background in biochemistry and molecular biology, Prof. Conrad has made significant contributions to understanding the interplay between metabolism and cell death pathways. His research aims to uncover novel therapeutic strategies for therapy-resistant cancers and other ferroptosis-related disorders, positioning him as a leading figure in the fields of cell biology and medicinal chemistry.